Related references
Note: Only part of the references are listed.
Article
Oncology
Metformin in Combination With Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer The OCOG-ALMERA Randomized Clinical Trial
Theodoros Tsakiridis et al.
Summary: This study aimed to investigate whether the addition of metformin to chemoradiotherapy could improve outcomes in patients with unresected locally advanced non-small cell lung cancer. However, the results showed that the addition of metformin was associated with worse treatment efficacy and increased toxic effects compared with combined modality therapy alone, indicating that metformin is not recommended in this patient population.
JAMA ONCOLOGY (2021)
Article
Health Care Sciences & Services
Performance of propensity score matching to estimate causal effects in small samples
Anais Andrilion et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2020)